Insulin glargine and the risk of cancer.
作者信息
Ahmed FA
机构信息
Isipingo Hospital, Natal, reports on data presented at the 2009 EASD congress
出版信息
Cardiovasc J Afr. 2010 Jan-Feb;21(1):49.
Abstract
摘要
相似文献
1
Insulin glargine and the risk of cancer.甘精胰岛素与癌症风险
Cardiovasc J Afr. 2010 Jan-Feb;21(1):49.
2
Insulin glargine and cancer--an unsubstantiated allegation.甘精胰岛素与癌症——毫无根据的指控。
Diabetes Technol Ther. 2009 Aug;11(8):473-6. doi: 10.1089/dia.2009.1705.
3
A possible link between insulin glargine and malignancy: the facts.甘精胰岛素与恶性肿瘤之间可能存在的联系：事实
Cardiovasc J Afr. 2009 Jul-Aug;20(4):216-8; discussion 218-9.
4
[Increased risk of cancer using insulin and insulin analogues?].使用胰岛素和胰岛素类似物会增加患癌风险吗？
MMW Fortschr Med. 2010 Sep 9;152(36):39-41. doi: 10.1007/BF03366975.
5
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.胰岛素抵抗与恶性肿瘤风险增加：甘精胰岛素数据的混杂因素
Diabetologia. 2010 Jan;53(1):206-8. doi: 10.1007/s00125-009-1535-0. Epub 2009 Sep 24.
6
German agency suspects that insulin analogue glargine increases risk of cancer.德国机构怀疑胰岛素类似物甘精胰岛素会增加患癌风险。
BMJ. 2009 Jul 8;339:b2774. doi: 10.1136/bmj.b2774.
7
Insulin glargine controversy: a tribute to the editorial team at Diabetologia.甘精胰岛素之争：向《糖尿病学》编辑团队致敬。
Diabetes. 2009 Nov;58(11):2427-8. doi: 10.2337/db09-9030.
8
Insulin glargine and cancer: another side to the story?甘精胰岛素与癌症：故事的另一面？
Lancet. 2009 Aug 15;374(9689):521. doi: 10.1016/S0140-6736(09)61477-X.
9
Insulin glargine and malignancy: an unwarranted alarm.甘精胰岛素与恶性肿瘤：无端警报。
Lancet. 2009 Aug 15;374(9689):511-3. doi: 10.1016/S0140-6736(09)61307-6. Epub 2009 Jul 17.
10
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.甘精胰岛素治疗糖尿病与恶性肿瘤风险：方法学缺陷与伦理问题
Diabetologia. 2010 Jan;53(1):204-5. doi: 10.1007/s00125-009-1572-8. Epub 2009 Oct 27.
本文引用的文献
1
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.在苏格兰使用甘精胰岛素与癌症发病率：苏格兰糖尿病研究网络流行病学组的一项研究。
Diabetologia. 2009 Sep;52(9):1755-65. doi: 10.1007/s00125-009-1453-1. Epub 2009 Jul 15.
2
Does diabetes therapy influence the risk of cancer?糖尿病治疗会影响患癌风险吗？
Diabetologia. 2009 Sep;52(9):1699-708. doi: 10.1007/s00125-009-1441-5.
3
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden.甘精胰岛素的使用与短期恶性肿瘤发病风险：一项基于人群的瑞典随访研究。
Diabetologia. 2009 Sep;52(9):1745-54. doi: 10.1007/s00125-009-1444-2. Epub 2009 Jul 9.
4
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.降糖治疗对 2 型糖尿病患者癌症风险的影响。
Diabetologia. 2009 Sep;52(9):1766-77. doi: 10.1007/s00125-009-1440-6. Epub 2009 Jul 2.
5
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.糖尿病患者使用人胰岛素或胰岛素类似物治疗的恶性肿瘤风险：一项队列研究。
Diabetologia. 2009 Sep;52(9):1732-44. doi: 10.1007/s00125-009-1418-4. Epub 2009 Jun 30.
Zotero 插件